SRUK is collaborating with private companies that are leaders in their fields with strong R&D departments. SRUK expects that by collaborating with private companies members will benefit from webinars on recent technological advances, networking opportunities, research mobility, and many others.
SRUK is open to explore mutually beneficial collaborations with other companies, Spanish or British, that are interested in reaching the Spanish research community in the UK. Please contact [email protected].
So far, SRUK is collaborating with NIM Genetics and Mind the Byte. They are leaders in their fields with strong R&D departments and SRUK members benefit from webinars provided on recent technological advances and further opportunities for contact with them. SRUK is open to explore mutually beneficial collaborations with other companies too.
NIMGenetics is a privately owned Spanish biomedical company specializing in the design and commercialization of products and services for clinical genetic diagnosis.
They develop exclusive genomic products and services essentially based on two technologies; microarrays and Next-generation sequencing. NIM Genetics has participated in the IV and V International Simposia SRUK/CERU (https://sruk2017.com/) sharing their experience in the development of a successful spin off company in Spain. They have also offer webinars on the state of the art of diagnostic techniques and their implementation in Spain.
Mind the Byte is a bioinformatics company specializing in computational drug discovery using a pay-per-use SaaS platform (Software as a Service).
Mind the Byte makes in-silico drug discovery accessible, scalable, and affordable to accelerate the development of new drugs through their platform and consultancy services. Mind the Byte have provided a hands-on webinar on computational drug discovery and how to use this methodology to find new potential therapies.